Published in Front Med (Lausanne) on October 14, 2016
Targeting Small Bowel Receptors to Treat Constipation and Diarrhea. Curr Gastroenterol Rep (2017) 0.75
Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep (2003) 3.32
Estimates of incidence and costs of intestinal infectious diseases in the United States. Public Health Rep (1988) 2.57
Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly. JAMA (1991) 1.69
P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide. J Nucl Med (2010) 1.62
European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr (2008) 1.55
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents (2000) 1.19
Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea. Gut (1992) 1.09
A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults. World J Gastroenterol (2005) 1.04
Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment. J Clin Oncol (1998) 1.03
Focus on acute diarrhoeal disease. World J Gastroenterol (2009) 1.01
Racecadotril. Drugs (2000) 0.99
An overview of clinical studies with racecadotril in adults. Int J Antimicrob Agents (2000) 0.98
Efficacy and tolerability of racecadotril in the treatment of cholera in adults: a double blind, randomised, controlled clinical trial. Gut (2003) 0.97
Alterations in rat intestinal transit by morphine promote bacterial translocation. Dig Dis Sci (1993) 0.96
Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. J Pharmacol Exp Ther (1986) 0.94
A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoea in adults. Scand J Gastroenterol (2002) 0.94
Racecadotril demonstrates intestinal antisecretory activity in vivo. Aliment Pharmacol Ther (1999) 0.92
A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril. Front Pharmacol (2012) 0.91
Comparison of racecadotril and loperamide in adults with acute diarrhoea. Aliment Pharmacol Ther (1999) 0.90
[An evidence based Iberic-Latin American guideline for acute gastroenteritis management in infants and prescholars]. An Pediatr (Barc) (2010) 0.90
Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet. Aliment Pharmacol Ther (1999) 0.89
Acetorphan prevents cholera-toxin-induced water and electrolyte secretion in the human jejunum. Eur J Gastroenterol Hepatol (1997) 0.88
Racecadotril versus placebo in the treatment of acute diarrhoea in adults. Aliment Pharmacol Ther (1999) 0.87
Probiotics for Prevention and Treatment of Diarrhea. J Clin Gastroenterol (2015) 0.86
The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide. Scand J Gastroenterol (1993) 0.86
Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites. Clin Infect Dis (2011) 0.85
Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors. Eur J Pharmacol (1987) 0.85
Enkephalins and enkephalinase inhibitors in intestinal fluid and electrolyte transport. Eur J Gastroenterol Hepatol (1997) 0.85
Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II study. Am J Clin Oncol (2000) 0.83
Racecadotril: a new approach to the treatment of diarrhoea. Int J Antimicrob Agents (2000) 0.82
Systematic review: the use of somatostatin or octreotide in refractory diarrhoea. Aliment Pharmacol Ther (2001) 0.82
Racecadotril versus loperamide: antidiarrheal research revisited. Dig Dis Sci (2003) 0.81
A comparative study of racecadotril and single dose octreotide as an anti-secretory agent in acute infective diarrhoea. J Assoc Physicians India (2012) 0.81
Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans. Eur J Pharmacol (1990) 0.80
Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteers. Aliment Pharmacol Ther (1992) 0.80
A new enkephalinase inhibitor as an alternative to loperamide in the prevention of diarrhea induced by CPT-11. J Clin Oncol (1995) 0.79
Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study. Eur J Gastroenterol Hepatol (1996) 0.78
Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.78
[Acetorphan, a potent enkephalinase inhibitor, does not modify orocecal and colonic transit times in healthy subjects]. Gastroenterol Clin Biol (1989) 0.77
Colon in acute intestinal infection. J Pediatr Gastroenterol Nutr (2009) 0.77
[Treatment of acute chemically induced diarrhea by inhibition of enkephalinase. Results of a pilot study]. Gastroenterol Clin Biol (1995) 0.77
[Loperamide for acute infectious diarrhoea]. Ned Tijdschr Geneeskd (2015) 0.76
[Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea]. Ann Gastroenterol Hepatol (Paris) (1993) 0.76